Skip to main content

Health condition

Histiocytosis adults (LCH)

Langerhans cell histiocytosis in adults is a rare clonal disorder in which abnormal immune cells infiltrate bone, skin, lungs or the pituitary; it is now understood as a treatable blood disorder, frequently driven by BRAF pathway mutations.

Why trust this guide

  • 01

    Editorial team

    Written by our editorial team from the UK sources listed on each page.

  • 02

    Sourced from guidance

    Checked against current NHS and UK specialist society guidance at the time of review.

  • 03

    Current for 2026

    Reviewed on 2026-09-27 with the next review scheduled for 2027-09-27.

Key facts

The essentials at a glance.

The symptoms to recognise, when to seek help, which specialist to see, and what treatment usually involves.

  • Adult presentations include bone lesions, rash, diabetes insipidus and cystic lung disease

  • Smoking is strongly linked to the isolated pulmonary form in adults

  • Most cases carry BRAF or MAP2K1 mutations, opening targeted treatment options

  • PET-CT maps disease extent and guides whether local or systemic treatment is needed

Understanding the condition

What it is and what happens next.

What causes it, how it is diagnosed, and the treatment routes available in the UK.

What it is and how it feels

Once considered a childhood curiosity, LCH is increasingly recognised in adults, where it can smoulder unrecognised: a punched-out skull lesion causing headache, a stubborn scalp or flexural rash, unquenchable thirst from pituitary involvement, or breathlessness from cystic lung disease in a smoker. The unifying finding is infiltration by clonal cells derived from the myeloid lineage.

Diagnosis and treatment routes

Management is stratified by extent. A single bone lesion may need only curettage or a modest intervention; pulmonary LCH demands absolute smoking cessation, which alone can stabilise it; multisystem disease is treated with systemic therapy, and BRAF or MEK inhibitors have produced striking responses in mutation-positive refractory disease. Adults benefit from review at centres with specific histiocytosis expertise, which exist in the UK. If you are waiting for results or want a second opinion on a proposed plan, a private consultation with a specialist who treats this condition regularly can usually be arranged quickly, and most will review your existing scans, biopsy reports and MDT correspondence.

Seeing a specialist

Who to see, and how quickly you can be seen.

The specialist for this condition is usually a consultant haematologist. Your GP can refer you on the NHS, or you can arrange a private consultation directly.

A quiet reminder

This guide is for information, not medical advice.

Your GP knows your history and can tell you which parts apply to you. If in doubt, see them - and seek urgent care for any of the emergency symptoms described above.

Frequently asked

Common questions about Histiocytosis adults (LCH).

Quick, plain-English answers to what people ask us most.

  • Can you explain what Histiocytosis adults (LCH) is?

    Histiocytosis adults (LCH) describes a recognised clinical condition that a doctor can diagnose based on your symptoms, history, and any relevant tests. Its impact varies from person to person, so a proper assessment is the best way to understand your own case. Your GP or a specialist can talk you through what it means in practice.

  • Why does histiocytosis adults (LCH) happen?

    Histiocytosis adults (LCH) can develop for a number of reasons, and the exact cause often depends on individual factors such as underlying health, lifestyle, or in some cases injury. A clinician will usually take a history and may arrange tests to identify what's driving it in your case. Understanding the underlying cause helps guide the most appropriate treatment.

  • What are the symptoms of histiocytosis adults (LCH)?

    The presentation of histiocytosis adults (LCH) differs between individuals, but it typically involves noticeable changes that prompt people to seek medical advice. Some people have mild symptoms that come and go, while others experience more persistent or severe effects. A clinical assessment is the most reliable way to confirm what's going on.

  • Is histiocytosis adults (LCH) serious or dangerous?

    Severity varies considerably, and while many cases are manageable with appropriate care, some can be more serious and need prompt attention. It's best not to self-diagnose severity, as similar symptoms can have very different underlying causes. A clinician can assess your specific situation and advise on the right next steps.

  • Does histiocytosis adults (LCH) run in families?

    There can be a hereditary element for some people, though many cases occur without any clear family link. If a close relative has been diagnosed with something similar, it's worth mentioning this to your doctor. This can help inform whether any additional monitoring or testing is worthwhile.

  • Can histiocytosis adults (LCH) be treated or reversed?

    Many cases can be effectively managed or improved with the right treatment, although whether it can be fully "cured" depends on the underlying cause. Early treatment generally gives the best chance of a good outcome. Your clinician can explain what's realistic to aim for in your specific case.

  • What treatment options are available for histiocytosis adults (LCH)?

    Depending on the cause and severity, treatment might involve medication, targeted therapy, monitoring, or in some cases a procedure. Most treatment plans start with the least invasive appropriate option and escalate only if needed. Your care team will personalise this based on your assessment and preferences.

  • How long does histiocytosis adults (LCH) last?

    Duration varies significantly depending on the cause, how promptly it's treated, and individual factors, so it's hard to give a single answer that applies to everyone. Some cases resolve within weeks with treatment, while others need longer-term management. Your clinician can give you a more specific timeframe once they understand your case fully.

  • When would I need to see a specialist for histiocytosis adults (LCH)?

    If first-line treatment isn't giving enough improvement, or if there are features that suggest a more complex underlying problem, a specialist referral is usually the next step. More invasive treatment is typically considered only after simpler options have been tried and haven't worked well enough. A specialist can assess whether this applies to your situation.

  • When is it worth getting histiocytosis adults (LCH) checked by a specialist?

    It's worth getting checked if things aren't improving, are getting worse, or are causing you ongoing worry or disruption. On the NHS, routine referrals for this kind of assessment can take 20-45+ weeks to come through; going private typically means being seen by a consultant within about 2 weeks.